Nymox Pharmaceutical
NYMX
#9275
Rank
C$24.75 M
Marketcap
Bahamas
Country
$0.27
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -$0.08142

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$0.08138. In 2022 the company made an earnings per share (EPS) of -$0.11 an increase over its 2021 EPS that were of -$0.20.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.08142-24.97%
2022-$0.11-46.67%
2021-$0.20-11.76%
2020-$0.23-15%
2019-$0.275.26%
2018-$0.26-26.92%
2017-$0.35-7.14%
2016-$0.38-40.43%
2015-$0.64291.67%
2014-$0.16-7.69%
2013-$0.18-43.48%
2012-$0.31-25.81%
2011-$0.4255%
2010-$0.2725%
2009-$0.220.08%
2008-$0.22-11.12%
2007-$0.24-0.16%
2006-$0.2428.59%
2005-$0.19-12.49%
2004-$0.22-16.05%
2003-$0.2619.07%
2002-$0.2214.45%
2001-$0.19-22.16%
2000-$0.245.64%
1999-$0.23-34.59%
1998-$0.35-3.6%
1997-$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.03-5,053.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.52-3,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.17-11,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.36-9,148.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.11-23,575.50%๐Ÿ‡บ๐Ÿ‡ธ USA